LIT Scientist Awarded Highly Competitive Grant
Gabriele Inchingolo, PhD student in Prof. Luca Gattinoni’s lab at the Leibniz Institute for Immunotherapy, has been selected as one of the winners of Bruker’s inaugural Beacon Discovery Global Grant Program.
Article Details
-
Date Published
September 11, 2025
Only three scientists were selected globally—one from each region (Americas, Europe/Middle East/Africa, and Asia Pacific/Japan)—and Gabriele’s project stood out, recognized as the sole awardee from Europe.
The grant, fully funded by Bruker—an American company and a global leader in live single-cell analysis—provides Gabriele with free access to the new Beacon Discovery™ Optofluidic System, launched in April at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Philadelphia. This groundbreaking platform performs real-time, multi-parametric single-cell analysis in a single workflow, integrating live-cell imaging, functional assays, and immune profiling with transcriptomic and TCR sequencing from the same cell.
With this opportunity, Gabriele will lead one of the very first projects worldwide using this cutting-edge platform, aiming to track and characterize rare alloreactive CAR T cell clones in patients after allogeneic CAR T cell therapy.
The winners of the inaugural Beacon Discovery Global Grant Program.
Additionally, Gabriele recently received “The 2025 Award for the Most Innovative Research in Hematology” by AIL (Italian Association Against Leukemia, Lymphoma and Myeloma), one of the main associations supporting Italian researchers, for the results achieved in the immunomonitoring of patients treated with CAR-modified Tscm cells. Gabriele received the prize directly from the National President of AIL, Dr. Giuseppe Toro, and the Regional President of AIL, Dr. Vito Leonetti, in his hometown in Italy.
The LIT warmly congratulates!
Left to right: Dr. Giuseppe Toro, National President of AIL; Dr. Vito Leonetti, President of AIL Puglia; Giovanna Bruno, Mayor of Andria (Gabriele’s hometown); and Dr. Giuseppe Tarantini, Coordinator of the Hematology Network in Puglia.
About Gabriele Inchingolo
Gabriele Inchingolo is currently a PhD student in Division for Functional Immune Cell Modulation. Gabriele graduated from the University of Bari in Medical Biotechnology and Molecular Medicine with honors. He has an academic and industrial background. His research interest is in the area of immuno-oncology and lymphocyte biology, with a particular focus on ex vivo T-cell engineering for cancer immunotherapy applications, T cell exhaustion, differentiation and memory formation.
Explore our Research Division in greater depth!
Get to know our team and find out more about our pioneering research.